Philippe V.
- Country
- France
- Department
- ICU
Research Overview
- Evaluation of Dobutamine Hydrochloride and Glucose Monohydrate in Septic Cardiomyopathy with Tissue Hypoperfusion: A Randomized Controlled Trial
- Evaluation of Early Levosimendan Administration Versus Placebo in Cardiogenic Shock Patients on Conventional Inotrope Therapy: A Morbidity-Mortality Endpoint Study
Data & Insights
Has run more than one trial at 4 of 34 partner sites.
Specializations
Cardiovascular Critical Care
Specialized in investigating therapeutic approaches for cardiogenic shock and advanced heart failure conditions. Focuses on evaluating the effectiveness of various inotropic agents in critical cardiac scenarios.
- Acute cardiac support strategies
- Advanced life support interventions
- Mechanical circulatory support
Studies the integration of conventional inotropic therapy with novel therapeutic agents in critical cardiac care settings.
Sepsis Management
Conducts research in the treatment of septic cardiomyopathy and its hemodynamic complications. Investigates targeted therapeutic approaches for patients with sepsis-induced cardiac dysfunction.
- Septic shock interventions
- Hemodynamic optimization
- Organ perfusion strategies
Explores the role of vasopressor support and fluid management in complex septic conditions.
Critical Care Therapeutics
Investigates comprehensive treatment strategies for tissue hypoperfusion in critical illness. Focuses on multi-organ support approaches in complex cardiovascular conditions.
- Renal support therapies
- Cardiovascular monitoring
- Multi-organ failure management
Studies outcomes in patients requiring advanced organ support interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.